Pre-order Enquiry
Request Free Sample
Global Next Generation Diabetes Therapy and Drug Delivery Market Insights and Forecast to 2028
SKU ID : QYR-20041944 | Publishing Date : 31-Jan-2022 | No. of pages : 112
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Next Generation Diabetes Therapy and Drug Delivery Market Insights and Forecast to 2028
1 Report Business Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Inhalable Insulin
1.2.3 Oral Insulin
1.2.4 Insulin Patches
1.2.5 CGM Systems
1.2.6 Artificial Pancreas
1.3 Market by Application
1.3.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Diagnostic/Clinics
1.3.3 ICUs
1.3.4 Home Healthcare
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Perspective (2017-2028)
2.2 Next Generation Diabetes Therapy and Drug Delivery Growth Trends by Region
2.2.1 Next Generation Diabetes Therapy and Drug Delivery Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Next Generation Diabetes Therapy and Drug Delivery Historic Market Size by Region (2017-2022)
2.2.3 Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Region (2023-2028)
2.3 Next Generation Diabetes Therapy and Drug Delivery Market Dynamics
2.3.1 Next Generation Diabetes Therapy and Drug Delivery Industry Trends
2.3.2 Next Generation Diabetes Therapy and Drug Delivery Market Drivers
2.3.3 Next Generation Diabetes Therapy and Drug Delivery Market Challenges
2.3.4 Next Generation Diabetes Therapy and Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Next Generation Diabetes Therapy and Drug Delivery Players by Revenue
3.1.1 Global Top Next Generation Diabetes Therapy and Drug Delivery Players by Revenue (2017-2022)
3.1.2 Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Players (2017-2022)
3.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Next Generation Diabetes Therapy and Drug Delivery Revenue
3.4 Global Next Generation Diabetes Therapy and Drug Delivery Market Concentration Ratio
3.4.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next Generation Diabetes Therapy and Drug Delivery Revenue in 2021
3.5 Next Generation Diabetes Therapy and Drug Delivery Key Players Head office and Area Served
3.6 Key Players Next Generation Diabetes Therapy and Drug Delivery Product Solution and Service
3.7 Date of Enter into Next Generation Diabetes Therapy and Drug Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Next Generation Diabetes Therapy and Drug Delivery Breakdown Data by Type
4.1 Global Next Generation Diabetes Therapy and Drug Delivery Historic Market Size by Type (2017-2022)
4.2 Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Type (2023-2028)
5 Next Generation Diabetes Therapy and Drug Delivery Breakdown Data by Application
5.1 Global Next Generation Diabetes Therapy and Drug Delivery Historic Market Size by Application (2017-2022)
5.2 Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Next Generation Diabetes Therapy and Drug Delivery Market Size (2017-2028)
6.2 North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Type
6.2.1 North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2017-2022)
6.2.2 North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2023-2028)
6.2.3 North America Next Generation Diabetes Therapy and Drug Delivery Market Share by Type (2017-2028)
6.3 North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Application
6.3.1 North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2017-2022)
6.3.2 North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2023-2028)
6.3.3 North America Next Generation Diabetes Therapy and Drug Delivery Market Share by Application (2017-2028)
6.4 North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country
6.4.1 North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2017-2022)
6.4.2 North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size (2017-2028)
7.2 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Type
7.2.1 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2017-2022)
7.2.2 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2023-2028)
7.2.3 Europe Next Generation Diabetes Therapy and Drug Delivery Market Share by Type (2017-2028)
7.3 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Application
7.3.1 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2017-2022)
7.3.2 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2023-2028)
7.3.3 Europe Next Generation Diabetes Therapy and Drug Delivery Market Share by Application (2017-2028)
7.4 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Country
7.4.1 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2017-2022)
7.4.2 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size (2017-2028)
8.2 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size by Type
8.2.1 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Share by Type (2017-2028)
8.3 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size by Application
8.3.1 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Share by Application (2017-2028)
8.4 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size by Region
8.4.1 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size (2017-2028)
9.2 Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Type
9.2.1 Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2017-2022)
9.2.2 Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2023-2028)
9.2.3 Latin America Next Generation Diabetes Therapy and Drug Delivery Market Share by Type (2017-2028)
9.3 Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Application
9.3.1 Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2017-2022)
9.3.2 Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2023-2028)
9.3.3 Latin America Next Generation Diabetes Therapy and Drug Delivery Market Share by Application (2017-2028)
9.4 Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country
9.4.1 Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2017-2022)
9.4.2 Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size (2017-2028)
10.2 Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size by Type
10.2.1 Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Share by Type (2017-2028)
10.3 Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size by Application
10.3.1 Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Share by Application (2017-2028)
10.4 Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size by Country
10.4.1 Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Introduction
11.1.4 Johnson & Johnson Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.1.5 Johnson & Johnson Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Introduction
11.2.4 Abbott Laboratories Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.2.5 Abbott Laboratories Recent Developments
11.3 Medtronic
11.3.1 Medtronic Company Details
11.3.2 Medtronic Business Overview
11.3.3 Medtronic Next Generation Diabetes Therapy and Drug Delivery Introduction
11.3.4 Medtronic Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.3.5 Medtronic Recent Developments
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Next Generation Diabetes Therapy and Drug Delivery Introduction
11.4.4 Sanofi Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.4.5 Sanofi Recent Developments
11.5 Novo Nordisk
11.5.1 Novo Nordisk Company Details
11.5.2 Novo Nordisk Business Overview
11.5.3 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Introduction
11.5.4 Novo Nordisk Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.5.5 Novo Nordisk Recent Developments
11.6 MannKind Corporation
11.6.1 MannKind Corporation Company Details
11.6.2 MannKind Corporation Business Overview
11.6.3 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Introduction
11.6.4 MannKind Corporation Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.6.5 MannKind Corporation Recent Developments
11.7 Enteris BioPharma
11.7.1 Enteris BioPharma Company Details
11.7.2 Enteris BioPharma Business Overview
11.7.3 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Introduction
11.7.4 Enteris BioPharma Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.7.5 Enteris BioPharma Recent Developments
11.8 Dexcom
11.8.1 Dexcom Company Details
11.8.2 Dexcom Business Overview
11.8.3 Dexcom Next Generation Diabetes Therapy and Drug Delivery Introduction
11.8.4 Dexcom Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.8.5 Dexcom Recent Developments
11.9 Senseonics
11.9.1 Senseonics Company Details
11.9.2 Senseonics Business Overview
11.9.3 Senseonics Next Generation Diabetes Therapy and Drug Delivery Introduction
11.9.4 Senseonics Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.9.5 Senseonics Recent Developments
11.10 Medtech
11.10.1 Medtech Company Details
11.10.2 Medtech Business Overview
11.10.3 Medtech Next Generation Diabetes Therapy and Drug Delivery Introduction
11.10.4 Medtech Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.10.5 Medtech Recent Developments
11.11 Synertech
11.11.1 Synertech Company Details
11.11.2 Synertech Business Overview
11.11.3 Synertech Next Generation Diabetes Therapy and Drug Delivery Introduction
11.11.4 Synertech Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.11.5 Synertech Recent Developments
11.12 Zosano Pharma
11.12.1 Zosano Pharma Company Details
11.12.2 Zosano Pharma Business Overview
11.12.3 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Introduction
11.12.4 Zosano Pharma Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.12.5 Zosano Pharma Recent Developments
11.13 Relmada Therapeutics
11.13.1 Relmada Therapeutics Company Details
11.13.2 Relmada Therapeutics Business Overview
11.13.3 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Introduction
11.13.4 Relmada Therapeutics Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.13.5 Relmada Therapeutics Recent Developments
11.14 Eli Lilly and Company
11.14.1 Eli Lilly and Company Company Details
11.14.2 Eli Lilly and Company Business Overview
11.14.3 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Introduction
11.14.4 Eli Lilly and Company Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.14.5 Eli Lilly and Company Recent Developments
11.15 Transdermal Specialties
11.15.1 Transdermal Specialties Company Details
11.15.2 Transdermal Specialties Business Overview
11.15.3 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Introduction
11.15.4 Transdermal Specialties Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
11.15.5 Transdermal Specialties Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Figures, Tables and Charts Available in Global Next Generation Diabetes Therapy and Drug Delivery Market Insights and Forecast to 2028
List of TablesTable 1. Global Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Inhalable Insulin
Table 3. Key Players of Oral Insulin
Table 4. Key Players of Insulin Patches
Table 5. Key Players of CGM Systems
Table 6. Key Players of Artificial Pancreas
Table 7. Global Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Region (2017-2022)
Table 11. Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Region (2023-2028)
Table 13. Next Generation Diabetes Therapy and Drug Delivery Market Trends
Table 14. Next Generation Diabetes Therapy and Drug Delivery Market Drivers
Table 15. Next Generation Diabetes Therapy and Drug Delivery Market Challenges
Table 16. Next Generation Diabetes Therapy and Drug Delivery Market Restraints
Table 17. Global Next Generation Diabetes Therapy and Drug Delivery Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Players (2017-2022)
Table 19. Global Top Next Generation Diabetes Therapy and Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Diabetes Therapy and Drug Delivery as of 2021)
Table 20. Ranking of Global Top Next Generation Diabetes Therapy and Drug Delivery Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Next Generation Diabetes Therapy and Drug Delivery Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Next Generation Diabetes Therapy and Drug Delivery Product Solution and Service
Table 24. Date of Enter into Next Generation Diabetes Therapy and Drug Delivery Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Type (2017-2022)
Table 28. Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Type (2023-2028)
Table 30. Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Application (2017-2022)
Table 32. Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Application (2023-2028)
Table 34. North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2023-2028) & (US$ Million)
Table 64. Johnson & Johnson Company Details
Table 65. Johnson & Johnson Business Overview
Table 66. Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Product
Table 67. Johnson & Johnson Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)
Table 68. Johnson & Johnson Recent Developments
Table 69. Abbott Laboratories Company Details
Table 70. Abbott Laboratories Business Overview
Table 71. Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Product
Table 72. Abbott Laboratories Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)
Table 73. Abbott Laboratories Recent Developments
Table 74. Medtronic Company Details
Table 75. Medtronic Business Overview
Table 76. Medtronic Next Generation Diabetes Therapy and Drug Delivery Product
Table 77. Medtronic Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)
Table 78. Medtronic Recent Developments
Table 79. Sanofi Company Details
Table 80. Sanofi Business Overview
Table 81. Sanofi Next Generation Diabetes Therapy and Drug Delivery Product
Table 82. Sanofi Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)
Table 83. Sanofi Recent Developments
Table 84. Novo Nordisk Company Details
Table 85. Novo Nordisk Business Overview
Table 86. Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Product
Table 87. Novo Nordisk Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)
Table 88. Novo Nordisk Recent Developments
Table 89. MannKind Corporation Company Details
Table 90. MannKind Corporation Business Overview
Table 91. MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Product
Table 92. MannKind Corporation Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)
Table 93. MannKind Corporation Recent Developments
Table 94. Enteris BioPharma Company Details
Table 95. Enteris BioPharma Business Overview
Table 96. Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Product
Table 97. Enteris BioPharma Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)
Table 98. Enteris BioPharma Recent Developments
Table 99. Dexcom Company Details
Table 100. Dexcom Business Overview
Table 101. Dexcom Next Generation Diabetes Therapy and Drug Delivery Product
Table 102. Dexcom Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)
Table 103. Dexcom Recent Developments
Table 104. Senseonics Company Details
Table 105. Senseonics Business Overview
Table 106. Senseonics Next Generation Diabetes Therapy and Drug Delivery Product
Table 107. Senseonics Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)
Table 108. Senseonics Recent Developments
Table 109. Medtech Company Details
Table 110. Medtech Business Overview
Table 111. Medtech Next Generation Diabetes Therapy and Drug Delivery Product
Table 112. Medtech Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)
Table 113. Medtech Recent Developments
Table 114. Synertech Company Details
Table 115. Synertech Business Overview
Table 116. Synertech Next Generation Diabetes Therapy and Drug Delivery Product
Table 117. Synertech Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)
Table 118. Synertech Recent Developments
Table 119. Zosano Pharma Company Details
Table 120. Zosano Pharma Business Overview
Table 121. Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Product
Table 122. Zosano Pharma Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)
Table 123. Zosano Pharma Recent Developments
Table 124. Relmada Therapeutics Company Details
Table 125. Relmada Therapeutics Business Overview
Table 126. Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Product
Table 127. Relmada Therapeutics Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)
Table 128. Relmada Therapeutics Recent Developments
Table 129. Eli Lilly and Company Company Details
Table 130. Eli Lilly and Company Business Overview
Table 131. Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Product
Table 132. Eli Lilly and Company Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)
Table 133. Eli Lilly and Company Recent Developments
Table 134. Transdermal Specialties Company Details
Table 135. Transdermal Specialties Business Overview
Table 136. Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Product
Table 137. Transdermal Specialties Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022) & (US$ Million)
Table 138. Transdermal Specialties Recent Developments
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Type: 2021 VS 2028
Figure 2. Inhalable Insulin Features
Figure 3. Oral Insulin Features
Figure 4. Insulin Patches Features
Figure 5. CGM Systems Features
Figure 6. Artificial Pancreas Features
Figure 7. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Application: 2021 VS 2028
Figure 8. Diagnostic/Clinics Case Studies
Figure 9. ICUs Case Studies
Figure 10. Home Healthcare Case Studies
Figure 11. Next Generation Diabetes Therapy and Drug Delivery Report Years Considered
Figure 12. Global Next Generation Diabetes Therapy and Drug Delivery Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Next Generation Diabetes Therapy and Drug Delivery Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Region: 2021 VS 2028
Figure 15. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Players in 2021
Figure 16. Global Top Next Generation Diabetes Therapy and Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Diabetes Therapy and Drug Delivery as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Next Generation Diabetes Therapy and Drug Delivery Revenue in 2021
Figure 18. North America Next Generation Diabetes Therapy and Drug Delivery Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Next Generation Diabetes Therapy and Drug Delivery Market Size Market Share by Type (2017-2028)
Figure 20. North America Next Generation Diabetes Therapy and Drug Delivery Market Size Market Share by Application (2017-2028)
Figure 21. North America Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Country (2017-2028)
Figure 22. United States Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Next Generation Diabetes Therapy and Drug Delivery Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Next Generation Diabetes Therapy and Drug Delivery Market Size Market Share by Type (2017-2028)
Figure 26. Europe Next Generation Diabetes Therapy and Drug Delivery Market Size Market Share by Application (2017-2028)
Figure 27. Europe Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Country (2017-2028)
Figure 28. Germany Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Region (2017-2028)
Figure 38. China Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Country (2017-2028)
Figure 48. Mexico Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Country (2017-2028)
Figure 54. Turkey Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Johnson & Johnson Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
Figure 58. Abbott Laboratories Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
Figure 59. Medtronic Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
Figure 60. Sanofi Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
Figure 61. Novo Nordisk Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
Figure 62. MannKind Corporation Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
Figure 63. Enteris BioPharma Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
Figure 64. Dexcom Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
Figure 65. Senseonics Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
Figure 66. Medtech Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
Figure 67. Synertech Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
Figure 68. Zosano Pharma Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
Figure 69. Relmada Therapeutics Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
Figure 70. Eli Lilly and Company Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
Figure 71. Transdermal Specialties Revenue Growth Rate in Next Generation Diabetes Therapy and Drug Delivery Business (2017-2022)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
Keyplayers in Global Next Generation Diabetes Therapy and Drug Delivery Market Insights and Forecast to 2028
Johnson & JohnsonAbbott Laboratories
Medtronic
Sanofi
Novo Nordisk
MannKind Corporation
Enteris BioPharma
Dexcom
Senseonics
Medtech
Synertech
Zosano Pharma
Relmada Therapeutics
Eli Lilly and Company
Transdermal Specialties
